The University of California, Irvine School of Medicine is an LCME accredited medical school, co-located in Orange County's cities of Irvine on the University of California, Irvine campus and Orange at the UC Irvine Medical Center.

During the past decade, Univ of California Irvine College of Medicine conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Univ of California Irvine College of Medicine" #1 sponsor was "Eli Lilly and Company" with 3 trials, followed by "AZTherapies, Inc." with 1 trials sponsored, "Hengrui Therapeutics, Inc." with 1 trials sponsored, "Ionis Pharmaceuticals, Inc." with 1 trials sponsored and "Roche Global Development" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Univ of California Irvine College of Medicine" #1 collaborator was "APCER Life Sciences" with 1 trials as a collaborator, "Alzheimer's Therapeutic Research Institute" with 1 trials as a collaborator, "KCAS Bio" with 1 trials as a collaborator and "PharmaConsulting Group" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Univ of California Irvine College of Medicine" are "Breast Cancer" (2 trials), "Cytomegalovirus Retinitis" (2 trials), "HIV Infections" (2 trials), "Metastatic Breast Cancer" (2 trials) and "Advanced Breast Cancer" (1 trials). Many other conditions were trialed in "Univ of California Irvine College of Medicine" in a lesser frequency.

Most popular intervention types in "Univ of California Irvine College of Medicine" are "Drug" (7 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Abemaciclib" (2 trials), "ALZT-OP1a" (1 trials), "ALZT-OP1b" (1 trials), "Alpelisib" (1 trials) and "Aromatase Inhibitor (AI)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Univ of California Irvine College of Medicine" are 6 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Univ of California Irvine College of Medicine". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Univ of California Irvine College of Medicine, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Univ of California Irvine College of Medicine, 2 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".